Tags

Type your tag names separated by a space and hit enter

Differentiation of pathologic/neoplastic hypercortisolism (Cushing syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as Pseudo-Cushing syndrome): response to Letter to the Editor.
Eur J Endocrinol 2018; 178(3):L3EJ

Authors+Show Affiliations

Endocrinology Center and ClinicsMedical College of Wisconsin, Menomonee Falls, Wisconsin, USA james.findling@froedtert.com.Departments of MedicineSurgery, and Physiology, Medical College of Wisconsin and Endocrine Research Laboratory, Aurora St Luke's Medical Center, Aurora Research Institute, Milwaukee, Wisconsin, USA.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

29440268

Citation

Findling, James W., and Hershel Raff. "Differentiation of Pathologic/neoplastic Hypercortisolism (Cushing Syndrome) From Physiologic/non-neoplastic Hypercortisolism (formerly Known as Pseudo-Cushing Syndrome): Response to Letter to the Editor." European Journal of Endocrinology, vol. 178, no. 3, 2018, p. L3.
Findling JW, Raff H. Differentiation of pathologic/neoplastic hypercortisolism (Cushing syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as Pseudo-Cushing syndrome): response to Letter to the Editor. Eur J Endocrinol. 2018;178(3):L3.
Findling, J. W., & Raff, H. (2018). Differentiation of pathologic/neoplastic hypercortisolism (Cushing syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as Pseudo-Cushing syndrome): response to Letter to the Editor. European Journal of Endocrinology, 178(3), p. L3. doi:10.1530/EJE-17-1034.
Findling JW, Raff H. Differentiation of Pathologic/neoplastic Hypercortisolism (Cushing Syndrome) From Physiologic/non-neoplastic Hypercortisolism (formerly Known as Pseudo-Cushing Syndrome): Response to Letter to the Editor. Eur J Endocrinol. 2018;178(3):L3. PubMed PMID: 29440268.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Differentiation of pathologic/neoplastic hypercortisolism (Cushing syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as Pseudo-Cushing syndrome): response to Letter to the Editor. AU - Findling,James W, AU - Raff,Hershel, PY - 2018/01/05/received PY - 2018/01/17/accepted PY - 2018/2/15/entrez PY - 2018/2/15/pubmed PY - 2018/4/27/medline SP - L3 EP - L3 JF - European journal of endocrinology JO - Eur. J. Endocrinol. VL - 178 IS - 3 SN - 1479-683X UR - https://www.unboundmedicine.com/medline/citation/29440268/Differentiation_of_pathologic/neoplastic_hypercortisolism_(Cushing_syndrome)_from_physiologic/non-neoplastic_hypercortisolism_(formerly_known_as_Pseudo-Cushing_syndrome):_response_to_Letter_to_the_Editor L2 - https://eje.bioscientifica.com/doi/10.1530/EJE-17-1034 DB - PRIME DP - Unbound Medicine ER -